ID

24461

Descripción

Visit 2 General Medical History - Physical Examination Findings form Study ID: 208127/125 Clinical Study ID: 208127/125 (Ext-HAB-038 Month 90) Study Title: A double-blind, randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' combined hepatitis A / hepatitis B vaccine in healthy children between 6 and 15 years of age. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B

Palabras clave

Versiones (1)
  1. 1/8/17 1/8/17 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

1 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125

Inglés

Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125

1 formularios  
Header
Descripción

Header

Alias
UMLS CUI-1
C1320722
Protocol
Descripción

Protocol

Tipo de datos

text

Alias
UMLS CUI [1]
C1507394
Activity
Descripción

Activity

Tipo de datos

text

Alias
UMLS CUI [1]
C1512346
Subject number
Descripción

Subject number

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
General Medical History
Descripción

General Medical History

Alias
UMLS CUI-1
C0262926
Has the subject taken any medication in the past 4 weeks ?
Descripción

if Yes, please complete the medication section

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013216
Is the subject suffering from or has he/she ever suffered from any SIGNIFICANT medical condition or undergone surgery ?
Descripción

If Yes, provide one diagnosis per line. In case of unclear diagnosis provide the significant signs or symptoms on separate lines.

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0973444
UMLS CUI [2]
C0543467
DIAGNOSIS / SIGNS AND SYMPTOMS
Descripción

DIAGNOSIS / SIGNS AND SYMPTOMS

Alias
UMLS CUI-1
C0011900
UMLS CUI-3
C0037088
PAST
Descripción

past

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0455458
CURRENT/ACTIVE
Descripción

current/active

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2707252
Volver a la parte superior de la página

Similar models

Visit 2 General Medical History Biologicals HepA/HepB vaccine 208127/125

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Header
C1320722 (UMLS CUI-1)
Protocol
Item
Protocol
text
C1507394 (UMLS CUI [1])
Activity
Item
Activity
text
C1512346 (UMLS CUI [1])
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item Group
General Medical History
C0262926 (UMLS CUI-1)
Medication in the past 4 weeks
Item
Has the subject taken any medication in the past 4 weeks ?
boolean
C0013216 (UMLS CUI [1])
Significant disease or undergone surgery
Item
Is the subject suffering from or has he/she ever suffered from any SIGNIFICANT medical condition or undergone surgery ?
boolean
C0973444 (UMLS CUI [1])
C0543467 (UMLS CUI [2])
Item Group
DIAGNOSIS / SIGNS AND SYMPTOMS
C0011900 (UMLS CUI-1)
C0037088 (UMLS CUI-3)
past
Item
PAST
boolean
C0455458 (UMLS CUI [1])
current/active
Item
CURRENT/ACTIVE
boolean
C2707252 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial